Rio Grande Neurosciences Acquires Cervel Neurotech’s Multi-Coil TMS Technology for Treating …

SANTA FE, N.M.–(BUSINESS WIRE)–Rio Grande Neurosciences, the leading provider of non-invasive brain stimulation (NIBS) electroceuticals™, today announced the completion of its acquisition of Cervel Neurotech’s multi-coil Transcranial Magnetic Stimulation (rTMS) technology, including all related patent applications, issued patents, trademarks and equipment. It will join targeted Pulse Electro Magnetic Field therapy (tPEMF) and closed-loop Transcranial Electrical Stimulation (cl-TES) as one of Rio Grande Neurosciences’ core technologies. Despite undergoing treatment with antidepressant medications, approximately four-and-a-half million people either do not respond to, or cannot tolerate the side effects of their medications. The use of repetitive TMS is a proven and FDA-approved therapy for the treatment of drug resistant major depressive disorder (MDD). The acquired patented rTMS system, which is based on foundational intellectual property developed at Stanford University, is unique in its…


Link to Full Article: Rio Grande Neurosciences Acquires Cervel Neurotech’s Multi-Coil TMS Technology for Treating …